<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt/107% Calibri Light; margin: 0 0 8pt; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">PURSUANT TO SECTION 13 OR 15 (D) OF THE</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report: April 9, 2018</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Stemcell Holdings, Inc.</U></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Small Business Issuer in its
charter)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 44%; font: 10pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Delaware</b></font></td>
    <td style="width: 15%; font: 10pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>000-55583</b></font></td>
    <td style="width: 41%; font: 10pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>36-4827622</b></font></td></tr>
<tr style="vertical-align: top">
    <td>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of incorporation</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">or organization)</P></td>
    <td style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</font></td>
    <td style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</font></td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>C/O Stemcell Co., Ltd., 5-9-15-3F,
Minamiaoyama</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Minato-ku, Tokyo, 107-0062, Japan</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Telephone: +81-3-3400-0707</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant's telephone number)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">-1-</P>




<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On April 9, 2018 the Board of Directors (the &quot;Board&quot;)
of Stemcell Holdings Inc. (the &quot;Company&quot;) approved the resignation of Ms. Erika, Nakazawa from the position of Chief
Financial Officer (&ldquo;CFO&rdquo;) effective on April 9, 2018. The resignation was not the result of any disagreement with
the Company on any matter relating to the Company&rsquo;s operations, policies or practices.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">On April 9, 2018
the Board approved the appointment of Ms. Rei Mochizuki as our new Chief Financial Officer, effective on April 9, 2018. </FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Ms. Rei Mochizuki, Age 46 - Chief Financial Officer</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Background of Ms. Rei Mochizuki</B>&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Ms. Mochizuki earned a BA and Masters
Degree in Commerce from Waseda university (Tokyo, Japan) and EMBA in Kellogg-HKUST business school. From July 2012 to February
2018 Mr. Mochizuka held the position of Finance Director at McCann Healthcare Communications Japan. Her responsibilities included
working with the Chief Executive Officer to direct all financial activities for the $100 million healthcare advertising and communication
business. She was also responsible for directing a fourteen person finance team including financial planning &amp; analysis (FP&amp;A).</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to Ms. Mochizuki&rsquo;s professional
experience in finance the board of directors has decided to appoint her to the position of Chief Financial Officer.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the date of this filing, there
has not been any material plan, contract or arrangement (written or unwritten) to which any of our officers or directors are
a party in connection with their appointments at Stemcell Holdings, Inc.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 8.01 Other Events.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Appointment of the New Officer of the Wholly Owned Subsidiary</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On April 9, 2018 Ms. Rei Mochizuki was appointed as the
Chief Financial Officer of Stemcell Co., Ltd., a Japan Corporation, which is our wholly owned subsidiary.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">None&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Stemcell Holdings, Inc.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Dated: April 9, 2018</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><U>By: /s/ Takaaki Matsuoka</U></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Takaaki Matsuoka</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">President, CEO and Director</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 242pt; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">-2-</P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "stemcell_8k4918.htm", "description": "FORM 8-K", "secsgml_size_bytes": 12616}]
{"company-data": {"conformed-name": "Stemcell Holdings, Inc.", "cik": "0001666487", "assigned-sic": "6770", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55583", "film-number": "18744580"}, "business-address": {"street1": "OMOTESANDO HELENE CLINIC 3-18-17-6F", "city": "MINAMIAOYAMA, MINATO-KU, TOKYO", "state": "M0", "zip": "107-0062", "phone": "401-641-0405"}, "mail-address": {"street1": "OMOTESANDO HELENE CLINIC 3-18-17-6F", "city": "MINAMIAOYAMA, MINATO-KU, TOKYO", "state": "M0", "zip": "107-0062"}, "former-company": {"former-conformed-name": "Perfect Acquisition, Inc.", "date-changed": "20160210"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: April 9, 2018
Stemcell Holdings, Inc.
(Name of Small Business Issuer in its
charter)
Delaware
000-55583
36-4827622
(State or other jurisdiction of incorporation
or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
C/O Stemcell Co., Ltd., 5-9-15-3F,
Minamiaoyama
Minato-ku, Tokyo, 107-0062, Japan
(Address of Principal Executive Offices)
Telephone: +81-3-3400-0707
(Registrant's telephone number)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
-1-
Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers.
On April 9, 2018 the Board of Directors (the "Board")
of Stemcell Holdings Inc. (the "Company") approved the resignation of Ms. Erika, Nakazawa from the position of Chief
Financial Officer ("CFO") effective on April 9, 2018. The resignation was not the result of any disagreement with
the Company on any matter relating to the Company's operations, policies or practices.
On April 9, 2018
the Board approved the appointment of Ms. Rei Mochizuki as our new Chief Financial Officer, effective on April 9, 2018.
Ms. Rei Mochizuki, Age 46 - Chief Financial Officer
Background of Ms. Rei Mochizuki
Ms. Mochizuki earned a BA and Masters
Degree in Commerce from Waseda university (Tokyo, Japan) and EMBA in Kellogg-HKUST business school. From July 2012 to February
2018 Mr. Mochizuka held the position of Finance Director at McCann Healthcare Communications Japan. Her responsibilities included
working with the Chief Executive Officer to direct all financial activities for the $100 million healthcare advertising and communication
business. She was also responsible for directing a fourteen person finance team including financial planning & analysis (FP&A).
Due to Ms. Mochizuki's professional
experience in finance the board of directors has decided to appoint her to the position of Chief Financial Officer.
As of the date of this filing, there
has not been any material plan, contract or arrangement (written or unwritten) to which any of our officers or directors are
a party in connection with their appointments at Stemcell Holdings, Inc.
Item 8.01 Other Events.
Appointment of the New Officer of the Wholly Owned Subsidiary
On April 9, 2018 Ms. Rei Mochizuki was appointed as the
Chief Financial Officer of Stemcell Co., Ltd., a Japan Corporation, which is our wholly owned subsidiary.
Item 9.01. Financial Statements and Exhibits.
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Stemcell Holdings, Inc.
Dated: April 9, 2018
By: /s/ Takaaki Matsuoka
Takaaki Matsuoka
President, CEO and Director
-2-